Roberts E F, Patel M V, Thompson G K. "一种塞瑞替尼杂质48的合成方法" [P]. US Patent, US 9701529 B2, 2020-02-22.
发明人冯建国,刘建华,孙丽萍. "Method for the Synthesis of Ceritinib Impurity 48" [P]. 中国发明专利, 专利号 CN 114992631 A, 授权公告日 2024-01-07.
Johansson L, Schröder R, Kowalski A. "A Process for Preparing High-Purity Ceritinib Impurity 48" [P]. European Patent, EP 3175865 A1, 2024-11-24.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质48 in Pharmaceutical Formulations". Anal. Methods, 2011, 2378, (1), 3765-3781.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质48 as an Impurity". J. Agric. Food Chem., 2018, 1529, 6717-6747.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 48 Using HRMS and NMR". Anal. Chem., 2021, 398, (5), 1843-1861.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质48 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2017, 1782, (6), 926-932.